MCRB - Seres Therapeutics GAAP EPS of -$0.57 misses by $0.02
2023-05-09 07:04:12 ET
- Seres Therapeutics press release ( NASDAQ: MCRB ): Q1 GAAP EPS of -$0.57 misses by $0.02 .
- Seres ended the first quarter of 2023 with $106.5 million in cash, cash equivalents and investments as compared with $181.3 million at the end of 2022.
For further details see:
Seres Therapeutics GAAP EPS of -$0.57 misses by $0.02